Evidence map›Paper›PMID 40799761›Full record

ArticleResearch square2025

Highly conserved

Regan E Schroeder, Safaa Ahmed, Anthony Ford, Mohammed Elfaki, Samuel Omer Hamad, Tarig Mohamed Elfaki Ahmed, Sumaia Mohamed, Emilia Manko, Taane G Clark, Susana Campino and 2 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Regan E SchroederDepartment of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, USA.
Safaa AhmedInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
Anthony FordDepartment of Bioinformatics and Genomics, University of North Carolina, Charlotte, NC, USA.
Mohammed ElfakiInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
Samuel Omer HamadInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
Tarig Mohamed Elfaki AhmedInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
Sumaia MohamedDepartment of Zoology, Faculty of Science, University of Khartoum, Khartoum, Sudan.
Emilia MankoDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Taane G ClarkDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Susana CampinoDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Muzamil Mahdi Abdel HamidInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
Eugenia LoDepartment of Microbiology and Immunology, College of Medicine, Drexel University, Philadelphia, USA.

Funding

Plasmodium vivax Erythrocyte Invasion Mechanisms and Humoral Immune Response in Duffy Negative AfricansR01AI162947 · NIAID · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI Eugenia Lo · 2022 to 2026
$3.4M
NIAID NIH HHS R01 AI162947
6 · The paper itself

Abstract

Duffy-negatives were previously thought to be immune to

Indexed as

Duffy Blood GroupEpidemiologyP. vivaxSingle Nucleotide PolymorphismSudanWhole Genome Sequencing

Identifiers

PMID40799761
PMCPMC12340914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.